Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Aquaporin and brain diseases.
An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients.
IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.
Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: The role of kallikrein-kinin system.
Rapidly progressive amyotrophic lateral sclerosis initially masquerading as a demyelinating neuropathy.
Nonallergic comorbidities of atopic eczema: an overview of systematic reviews.
Subcutaneous IgG in neurologic diseases.
Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline.
Lysophospholipids and their receptors in the central nervous system.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients.
Combining two multiple sclerosis treatments has no clinical benefit, study finds.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes.
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
MAIT cells in autoimmunity.
Pages
« first
‹ previous
…
402
403
404
405
406
407
408
409
410
…
next ›
last »